AbbVie Inc. Form 424B5: Prospectus (Rule 424(b)(5))
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-06: Form 424B5; Description 424B5; Document tm2621452-3_424b5.htm.
- 2026-08-04: Form 424B5; Description 424B5; Document tm2621452-1_424b5.htm.
- 2026-02-26: Form 424B5; Description 424B5; Document tm266774-2_424b5.htm.
- 2026-02-24: Form 424B5; Description 424B5; Document tm266774-1_424b5.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-06 | 424B5 | 424B5 | tm2621452-3_424b5.htm | |
| 2026-08-04 | 424B5 | 424B5 | tm2621452-1_424b5.htm | |
| 2026-02-26 | 424B5 | 424B5 | tm266774-2_424b5.htm | |
| 2026-02-24 | 424B5 | 424B5 | tm266774-1_424b5.htm | |
| 2025-02-20 | 424B5 | 424B5 | tm255723-6_424b5.htm | |
| 2025-02-18 | 424B5 | 424B5 | tm255723-3_424b5.htm | |
| 2024-02-26 | 424B5 | 424B5 | tm246405-2_424b5.htm | |
| 2024-02-21 | 424B5 | 424B5 | tm246405-1_424b5.htm | |
| 2019-09-19 | 424B5 | 424B5 | a2239707z424b5.htm | |
| 2018-09-17 | 424B5 | 424B5 | a2236713z424b5.htm | |
| 2018-09-13 | 424B5 | 424B5 | a2236696z424b5.htm | |
| 2016-11-16 | 424B5 | 424B5 | a2230297z424b5.htm | |
| 2016-05-11 | 424B5 | 424B5 | a2228610z424b5.htm | |
| 2015-05-07 | 424B5 | 424B5 | a2224624z424b5.htm | |
| 2015-05-05 | 424B5 | 424B5 | a2224624z424b5.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |